• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ESSENTIAL MEDICAL, INC. MANTA 18F; MANTA VASCULAR CLOSURE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ESSENTIAL MEDICAL, INC. MANTA 18F; MANTA VASCULAR CLOSURE DEVICE Back to Search Results
Catalog Number 2115NE
Medical Device Problem Code Material Too Rigid or Stiff (1544)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/27/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Udi will be provided with the follow up report.
 
Event or Problem Description
It was reported that: "tavi procedure, the membrane of the manta sheath was stiff, and the manta catheter couldn't penetrate it.The doctor had to take new device, and that was ok." anatomical insertion site of device: right femoral artery.Device removed and a new manta kit was used.Therapy delayed due to this but not harm to the patient.".
 
Additional Manufacturer Narrative
Qn#(b)(4).One unit of manta and sheath were returned for evaluation.Blood particulates were noted on the unit.Unit was decontaminated and in spected.Minor tear was observed on the button valve.The unit was functionally tested for advancement.The bypass tube passed through the valve but dismantled a piece of the button valve within the lumen of the sheath.No significant resistance was noted.The device lot history record review for lot number mn2401578 manta 18f ce indicated no non-conformities related to this lot, therefore supporting the device met material, assembly, and performance specifications before shipment.The case details were reviewed.A centrally positioned access was gained utilizing micropuncture with ultrasound for guidance.The right common femoral arteriotomy was clear of calcification.No issues were encountered in advancing or withdrawing the procedural sheaths during the case.Following the tavi, heparin and protamine were administered, and an 18f ce manta was deployed to the measured depth for closure.While inserting the bypass tube through the hemostatic valve of the manta sheath, the surgeon encountered resistance attempting to advance the bypass tube into the sheath hub.The first 18f ce manta device and sheath were removed, and a new 18f ce manta device and sheath (same lot number) were loaded and deployed successfully.A capa was previously opened under teleflex quality system to address this issue.Further investigation related to this event will be initiated if the occurrence rate exceeds the limit as per the capa.The der process will continue to monitor for any similar events.
 
Event or Problem Description
It was reported that: "tavi procedure, the membrane of the manta sheath was stiff, and the manta catheter couldn't penetrate it.The doctor had to take new device, and that was ok" anatomical insertion site of device: right femoral artery.Device removed and a new manta kit was used.Therapy delayed due to this but not harm to the patient.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MANTA 18F
Common Device Name
MANTA VASCULAR CLOSURE DEVICE
Manufacturer (Section D)
ESSENTIAL MEDICAL, INC.
exton
Manufacturer (Section G)
ESSENTIAL MEDICAL, INC.
260 sierra drive
exton
Manufacturer Contact
kevin don bosco
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key21696347
Report Number3010252479-2025-00032
Device Sequence Number15620161
Product Code MGB
UDI-Device Identifier00856279007062
UDI-Public(01)00856279007062(11)240422(17)251031(10)MN2401578(21)
Combination Product (Y/N)N
Initial Reporter CountryIS
PMA/510(K) Number
P180025
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 03/06/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2025
Device Catalogue Number2115NE
Device Lot NumberMN2401578
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/06/2025
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date03/26/2025
Supplement Report FDA Received Date04/23/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/22/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NOT REPORTED; NOT REPORTED
Patient SexUnknown
-
-